Dexmedetomidine hydrochloride - Drug Shortage Information

Public shortage context is available across 8 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Current and historical shortage references are available across related Dexmedetomidine hydrochloride presentations from multiple manufacturers.

3 current shortage context pages.
5 historical shortage context pages.
4 manufacturers represented.

Related research paths

Dexmedetomidine hydrochloride catalog familyBrowse all visible Dexmedetomidine hydrochloride presentations in the broader catalog.Hospira, Inc.4 shortage-bearing exact NDC pages.Fresenius Kabi USA, LLC2 shortage-bearing exact NDC pages.Baxter Healthcare Company1 shortage-bearing exact NDC page.

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

dexmedetomidine hydrochloride 100 ug / mL Injection 2 mL - NDC 63323-0421-02Fresenius Kabi USA, LLC | 25 Vial Dexmedetomidine Hydrochloride 4 ug / mL Injection 250 mL (Precedex) - NDC 00409-1434-01Hospira, Inc. | 1 Bottle Dexmedetomidine Hydrochloride 4 ug / mL Injection 100 mL (Precedex) - NDC 00409-1660-10Hospira, Inc. | 10 Bottle Dexmedetomidine Hydrochloride 200 ug / 50mL Injection 50 mL - NDC 00338-9555-24Baxter Healthcare Company | 24 Bag Dexmedetomidine Hydrochloride 4 ug / mL Injection 20 mL - NDC 63323-0671-20Fresenius Kabi USA, LLC | 10 Vial, Single-Dose

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug Name	NDC 11	Manufacturer	Shortage Context
dexmedetomidine hydrochloride 100 ug / mL Injection 2 mL NDC 63323-0421-02 \| 25 Vial \| Fresenius Kabi USA, LLC	63323-0421-02	Fresenius Kabi USA, LLC	Current shortage context
Dexmedetomidine Hydrochloride 4 ug / mL Injection 250 mL (Precedex) NDC 00409-1434-01 \| 1 Bottle \| Hospira, Inc.	00409-1434-01	Hospira, Inc.	Current shortage context
Dexmedetomidine Hydrochloride 4 ug / mL Injection 100 mL (Precedex) NDC 00409-1660-10 \| 10 Bottle \| Hospira, Inc.	00409-1660-10	Hospira, Inc.	Current shortage context
Dexmedetomidine Hydrochloride 200 ug / 50mL Injection 50 mL NDC 00338-9555-24 \| 24 Bag \| Baxter Healthcare Company	00338-9555-24	Baxter Healthcare Company	Historical shortage context
Dexmedetomidine Hydrochloride 4 ug / mL Injection 20 mL NDC 63323-0671-20 \| 10 Vial, Single-Dose \| Fresenius Kabi USA, LLC	63323-0671-20	Fresenius Kabi USA, LLC	Historical shortage context
Dexmedetomidine Hydrochloride 4 ug / mL Injection 100 mL NDC 00143-9525-10 \| 10 Pouch \| Hikma Pharmaceuticals USA Inc.	00143-9525-10	Hikma Pharmaceuticals USA Inc.	Historical shortage context
Dexmedetomidine Hydrochloride 4 ug / mL Injection 20 mL (Precedex) NDC 00409-1660-20 \| 10 Vial \| Hospira, Inc.	00409-1660-20	Hospira, Inc.	Historical shortage context
Dexmedetomidine Hydrochloride 4 ug / mL Injection 50 mL (Precedex) NDC 00409-1660-50 \| 20 Bottle \| Hospira, Inc.	00409-1660-50	Hospira, Inc.	Historical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.